Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Avenue Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ATXI alerts

About Lucy Lu

Lucy Lu is recorded as CFO at Avenue Therapeutics, Inc. (ATXI) since January 7, 2022. The proxy statement of Avenue Therapeutics, Inc. reports total compensation of $570,859 for Lucy Lu in fiscal 2022, including a base salary of $158,659. Disclosed compensation is on record for 5 fiscal years. Avenue Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Avenue Therapeutics, Inc. includes Alexandra MacLean (CEO and Board Member), Alexandra MacLean, M.D. (CEO and Board Member), Jay Kranzler, M.D., Ph.D. (Chairman and Board Member) and 7 others.

Affiliation history

Company network

Leadership on record at Avenue Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Avenue Therapeutics, Inc. (ATXI) $158,659 $570,859
2021 Avenue Therapeutics, Inc. (ATXI) $454,647 $1,082,128
2020 Avenue Therapeutics, Inc. (ATXI) $431,627 $443,027
2019 Avenue Therapeutics, Inc. (ATXI) $419,055 $639,783
2018 Avenue Therapeutics, Inc. (ATXI) $406,850 $1,594,633

Recent activity

No call appearances or filed executive changes recorded yet.